US biotechnology company Moderna Inc, one of the two leading makers of mRNA vaccines for COVID-19, on Tuesday announced that it would establish four subsidiaries in Taiwan, Hong Kong, Malaysia and Singapore to support delivery of its vaccines and therapeutics.
The subsidiary in Taiwan is expected to be set up by the end of this year, Moderna told Chinese-language media, adding that it would recruit local talent and collaborate with local hospitals on clinical trials.
Moderna has signed a contract with Taiwan to offer 20 million COVID-19 vaccine and booster doses this year, and another 15 million next year, the company said in a statement.
Photo: Reuters
In Taiwan, its COVID-19 vaccine has been approved for people aged 18 or older, while its booster shots can be given to those who had their second dose five months prior, it said.
Moderna provides Taiwan with its mRNA-1273 vaccine, which targets variants of SARS-CoV-2, and it is developing a next-generation vaccine that it expects to launch in the second half of this year, pending regulatory approval, Moderna senior vice president Patrick Bergstedt said in an interview with the Chinese-language United Daily News.
“This is why we set up a subsidiary in Taiwan — we hope to cooperate with local hospitals and regulators directly so that we could provide our vaccine,” United Daily News quoted Bergstedt as saying.
More studies are required to determine whether booster shots should be given once every six months or once a year, he said.
Moderna did not say whether it would consider manufacturing its COVID-19 vaccine in Taiwan, but the Central News Agency (CNA) yesterday reported that the government is attempting to arrange a technology transfer for the vaccine.
To facilitate a transfer, the government plans to set up a new company in which the National Development Fund would hold a stake of less than 49 percent and the remaining shares would belong to private companies, CNA reported.
South Korea’s Samsung Biologics Co has since May last year been assigned the fill and finish manufacturing task for Moderna’s COVID-19 vaccines, corporate data showed.
Minister of Health and Welfare Chen Shih-chung (陳時中) last year told lawmakers that the US is protective of its mRNA technology, so there would be a higher chance of Taiwan participating in the back-end manufacturing processes, such as fill and finish — the process of filling vials with vaccine and finishing the process of packaging the medicine — than in core manufacturing.
However, Taiwan would strive to transfer the technology, he said.
Asked whether Moderna’s decision to set up a branch in Taiwan could lead to the company’s vaccines being produced in Taiwan or other types of cooperation, Chen yesterday said that the ministry does not know the company’s development plans, but welcomes it to Taiwan and would not exclude the possibility of further cooperation.
Moderna said that the addition of the four subsidiaries comes as it continues to scale up the manufacturing and distribution of its COVID-19 vaccine, and future mRNA vaccines and therapeutics.
The Asia-Pacific region represents an integral part of Moderna’s business, with established subsidiaries in Australia, South Korea and Japan, it said.
Additional reporting by Lee I-chia
The domestically designed Teng Yun 2 drone passed development milestones over the weekend, flying for more than 10 hours straight and circling Taiwan’s air defense identification zone (ADIZ), in the longest flight of an indigenous uncrewed combat aerial vehicle. Developed by the Chungshan Institute of Science and Technology, the Teng Yun 2, or “Cloud Rider” (騰雲二型), recorded its longest flight yet over the weekend, after a three-hour test flight last month, followed by five and seven-hour stretches in the air. The Teng Yun 2 No. 1812 departed from Chiashan Air Base in Hualien County at 6:46pm on Saturday and flew on a
A slew of new measures are to take effect on Friday, including nationwide bring-your-own-cup discounts. The new rule requires chain beverage shops to offer discounts of at least NT$5 (US$0.17) to customers who bring their own cups, the Environmental Protection Agency (EPA) has said. The policy would apply to more than 50,000 chain retail locations, including beverage shops, convenience stores, fast-food restaurants and supermarkets. It aims to cut down on waste from single-use plastic cups, more than 2.2 billion of which were used in Taiwan in 2020, the agency said. For convenience, the EPA said it has asked retailers to display signs stating how
TIMING: 'The CHIPS Act funding is crucial for us. In other words, if the act’s passage is delayed for too long, we will certainly need to adjust,’ chairwoman Doris Hsu said GlobalWafers Co (環球晶圓) plans to start construction on a US$5 billion wafer fabrication facility in Texas in November, after passage of the US$52 billion Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act. The fab would be the largest of its kind in the US and one of the largest in the world, with a monthly capacity of 1.2 million wafers, GlobalWafers said, adding that the investment would be the first new fab in the US in more than 20 years and critical to closing a semiconductor supply chain gap. The world’s No. 3 silicon wafer supplier said the project, which
COUNTERING CHINA: ‘When democracies demonstrate what we can do ... I have no doubt that we’ll win that competition every time,’ US President Joe Biden said US President Joe Biden rebooted his effort to counter China’s Belt and Road Initiative (BRI) after an earlier campaign faltered, enlisting the support of G7 leaders at their summit in Germany. The Build Back Better World initiative, named after Biden’s domestic spending and climate agenda, struggled to get off the ground because not enough G7 partners contributed financially when it was unveiled a year ago, people familiar with its lack of progress said. “When democracies demonstrate what we can do — all that we have to offer — I have no doubt that we’ll win that competition every time,” Biden said during
RSS